全文获取类型
收费全文 | 1204篇 |
免费 | 117篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 63篇 |
妇产科学 | 41篇 |
基础医学 | 189篇 |
口腔科学 | 36篇 |
临床医学 | 221篇 |
内科学 | 207篇 |
皮肤病学 | 42篇 |
神经病学 | 43篇 |
特种医学 | 158篇 |
外科学 | 89篇 |
综合类 | 75篇 |
一般理论 | 1篇 |
预防医学 | 69篇 |
眼科学 | 6篇 |
药学 | 92篇 |
中国医学 | 1篇 |
肿瘤学 | 32篇 |
出版年
2022年 | 9篇 |
2021年 | 18篇 |
2020年 | 11篇 |
2019年 | 12篇 |
2018年 | 30篇 |
2017年 | 7篇 |
2015年 | 16篇 |
2014年 | 26篇 |
2013年 | 48篇 |
2012年 | 20篇 |
2011年 | 35篇 |
2010年 | 41篇 |
2009年 | 33篇 |
2008年 | 29篇 |
2007年 | 53篇 |
2006年 | 28篇 |
2005年 | 29篇 |
2004年 | 27篇 |
2003年 | 28篇 |
2002年 | 25篇 |
2001年 | 42篇 |
2000年 | 40篇 |
1999年 | 54篇 |
1998年 | 54篇 |
1997年 | 40篇 |
1996年 | 40篇 |
1995年 | 31篇 |
1994年 | 23篇 |
1993年 | 27篇 |
1992年 | 38篇 |
1991年 | 28篇 |
1990年 | 26篇 |
1989年 | 52篇 |
1988年 | 57篇 |
1987年 | 37篇 |
1986年 | 31篇 |
1985年 | 48篇 |
1984年 | 22篇 |
1983年 | 15篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1980年 | 12篇 |
1979年 | 5篇 |
1978年 | 15篇 |
1977年 | 19篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1973年 | 9篇 |
1972年 | 15篇 |
排序方式: 共有1367条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
96.
97.
Innervation of supporting cells in the apical turns of the guinea pig cochlea is from type II afferent fibers 总被引:3,自引:0,他引:3
Fechner FP Nadol JB JR Burgess BJ Brown MC 《The Journal of comparative neurology》2001,429(2):289-298
The outer supporting cells in the apical turns of the guinea pig cochlea receive a dense innervation. Our previous study (Fechner et al. [1998] J. Comp. Neurol. 400:299-300) suggested that this innervation of the Deiters' and Hensen's supporting cells was not derived from efferent fibers of the olivocochlear bundle, but its origin has not been further specified. To test the hypothesis that the innervation was afferent in origin, we traced apical afferent fibers that were retrogradely labeled by extracellular injections of horseradish peroxidase. Labeled afferent fibers were of two types: type I fibers contacted inner hair cells, whereas type II fibers crossed the tunnel and contacted outer hair cells. Significantly, most of the type II fibers also formed branches to the outer supporting cells. Although a few olivocochlear efferent fibers formed such branches, counts indicated that the overwhelming majority of the branches were produced by type II afferent fibers. These branches were not produced by basal type II fibers. Apical type II fibers also differed from basal fibers by having shorter lengths, spiraling both apically and basally, and contacting all three rows of outer hair cells. These innervation differences suggest differences in the ways that information from outer hair cells is processed in the apex versus the base of the cochlea. 相似文献
98.
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura 总被引:11,自引:0,他引:11
Bussel JB; Kimberly RP; Inman RD; Schulman I; Cunningham-Rundles C; Cheung N; Smithwick EM; O'Malley J; Barandun S; Hilgartner MW 《Blood》1983,62(2):480-486
High-dose intravenous gammaglobulin (IVIgG) was given to 12 children and adults with chronic idiopathic thrombocytopenic purpura (ITP) to avoid splenectomy or because they either failed to respond to or required maintenance with high doses of steroids and/or immunosuppressives. The average platelet count increase to initial therapy was 239,500/microliters (range 23,000-790,000). A concomitant IgG Fc receptor blockade, measured by IgG-sensitized 51Cr-labeled autologous erythrocytes, was seen in 11 of 11 patients tested, both splenectomized and not splenectomized, lasting 3-4 wk. Six or more months after treatment, 2 children are in remission, 2 children and 2 adults are stable requiring no therapy with platelet counts of approximately 50,000 and 30,000, respectively, 3 children require maintenance IVIgG therapy at 2-10-wk intervals, and 1 child and 2 adults have become refractory to further IVIgG. Splenectomy was not performed in 4 children. Two adults were able to discontinue daily prednisone. The 3 patients who became unresponsive to Swiss Red Cross gamma-globulin (IgSRK) therapy did so in conjunction with a markedly elevated platelet-associated IgG and IgM. Serum IgM increased an average of 103 mg/dl after the IVIgG infusions. No significant side effects were seen. 相似文献
99.
Meckel-Gruber syndrome. Importance of prenatal diagnosis 总被引:1,自引:0,他引:1
D A Nyberg D Hallesy B S Mahony J H Hirsch D A Luthy D Hickok 《Journal of ultrasound in medicine》1990,9(12):691-696
Prenatal sonographic findings are reported in six fetuses with the Meckel-Gruber syndrome to illustrate the variety of sonographic findings associated with this disorder and to emphasize the importance of prenatal sonography in helping to establish the correct diagnosis. All six fetuses demonstrated evidence of renal cystic dysplasia. In five cases the kidneys were large and echogenic, demonstrating small discrete cysts in the range of 2 to 5 mm. The remaining fetus demonstrated unilateral renal cystic dysplasia and contralateral renal agenesis. Oligohydramnios was noted in all cases and was evident as early as 14 weeks. An occipital cephalocele was demonstrated on sonography in each case although the size and contents of the cephalocele varied significantly. Two fetuses, both in the same family, also demonstrated a cystic mass in the posterior fossa and partial absence of the cerebellum consistent with a Dandy-Walker variant or cerebellar hypoplasia. The concurrence of marked oligohydramnios and bilateral severe renal anomalies should initiate a search for anomalies of the central nervous system indicative of the Meckel-Gruber syndrome. Recurrence of Meckel-Gruber syndrome may be evaluated as soon as 14 weeks, but it may not be reliably excluded until 20 weeks. 相似文献
100.
M Chernesky J Mahony S Castriciano L Sekla F Bishai S Vas 《Journal of medical virology》1986,20(3):269-277
A total of 362 sera from 295 Canadian patients were examined for HBsAg, anti-HBs, anti-HBc, anti-HBcIgM, HBeAg, and anti-HBe using commercial immunoassays. Serial samples from 70 acutely infected patients demonstrated that anti-HBcIgM may detect 10% more positives than HBsAg within 4 months after the onset of clinical symptoms, and all except two were negative for anti-HBcIgM after the fourth month. None of 66 asymptomatic (HBeAg rate 18.2%) and two of 14 (14.3%) symptomatic (HBeAg rate 64.3%) carriers of HBsAg were positive for anti-HBcIgM (P = 0.029). Elevated marker responses were measured in two symptomatic carriers for a 20-month period. Anti-HBcIgM was not detected in either 100 asymptomatic patients positive for total anti-HBc, negative for HBsAg and negative for or possessing low levels of anti-HBs, 25 patients with liver disorders not caused by HBV, or 20 healthy milk donors. In diagnostic laboratory practice this anti-HBcIgM test may be useful in the following situations: to supplement HBsAg testing, providing a theoretical 10% increase in positives within 4 months following onset of acute viral hepatitis; to replace testing for anti-HBc and anti-HBs in symptomatic HBsAg-negative patients; to confirm whether a patient is experiencing acute or chronic HBV infection or symptoms superimposed upon asymptomatic HBsAg carriage by another cause, such as nonA-nonB viral hepatitis. 相似文献